282 related articles for article (PubMed ID: 31403185)
41. An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients.
Xu C; Wang RY; Schechterly CA; Ge S; Shih JW; Xia NS; Luban NL; Alter HJ
Transfusion; 2013 Oct; 53(10 Pt 2):2505-11. PubMed ID: 23829163
[TBL] [Abstract][Full Text] [Related]
42. Hepatitis E virus seroepidemiology and its change during 1 year in primary school students in Ankara, Turkey.
Maral I; Budakoglu II; Ceyhan MN; Atak A; Bumin MA
Clin Microbiol Infect; 2010 Jul; 16(7):831-5. PubMed ID: 19778297
[TBL] [Abstract][Full Text] [Related]
43. Ongoing subclinical infection of hepatitis E virus among blood donors with an elevated alanine aminotransferase level in Japan.
Gotanda Y; Iwata A; Ohnuma H; Yoshikawa A; Mizoguchi H; Endo K; Takahashi M; Okamoto H
J Med Virol; 2007 Jun; 79(6):734-42. PubMed ID: 17457924
[TBL] [Abstract][Full Text] [Related]
44. Hepatitis E virus infection in different groups of Estonian patients and people who inject drugs.
Kuznetsova TV; Ivanova-Pozdejeva A; Reshetnjak I; Geller J; Värv K; Rumvolt R; Vikentjeva M; Trubnikova EV; Pozdniakova NV; Shevelev AB; Golovljova I
J Clin Virol; 2018 Jul; 104():5-10. PubMed ID: 29702351
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of antibodies to hepatitis E virus among Japanese blood donors: identification of three blood donors infected with a genotype 3 hepatitis E virus.
Fukuda S; Sunaga J; Saito N; Fujimura K; Itoh Y; Sasaki M; Tsuda F; Takahashi M; Nishizawa T; Okamoto H
J Med Virol; 2004 Aug; 73(4):554-61. PubMed ID: 15221899
[TBL] [Abstract][Full Text] [Related]
46. Epidemiology of hepatitis E virus infection in a cohort of 4023 immunocompromised patients.
Harritshøj LH; Hother CE; Sengeløv H; Daugaard G; Sørensen SS; Jacobsen S; Perch M; Holm DK; Sækmose SG; Aagaard B; Erikstrup C; Hogema BM; Lundgren JD; Ullum H
Int J Infect Dis; 2020 Feb; 91():188-195. PubMed ID: 31756566
[TBL] [Abstract][Full Text] [Related]
47. [Hepatitis E virus seroprevalence in blood donors in a university hospital in Chile].
Covarrubias N; Naveas P; Miranda J; Hurtado C; Vera DB; Larrondo M; Brahm J; Venegas M
Rev Chilena Infectol; 2018 Aug; 35(4):455-457. PubMed ID: 30534936
[TBL] [Abstract][Full Text] [Related]
48. [Hepatitis E virus seropositivity in hemodialysis patients in Hatay province, Turkey].
Uçar E; Cetin M; Kuvandik C; Helvaci MR; Güllü M; Hüzmeli C
Mikrobiyol Bul; 2009 Apr; 43(2):299-302. PubMed ID: 19621616
[TBL] [Abstract][Full Text] [Related]
49. Seroprevalence of anti-hepatitis E virus (HEV) in a Korean population: comparison of two commercial anti-HEV assays.
Park HK; Jeong SH; Kim JW; Woo BH; Lee DH; Kim HY; Ahn S
BMC Infect Dis; 2012 Jun; 12():142. PubMed ID: 22726615
[TBL] [Abstract][Full Text] [Related]
50. Detection and characterization of hepatitis E virus genotype 3 in HIV-infected patients and blood donors from southern Brazil.
Moss da Silva C; Oliveira JM; Mendoza-Sassi RA; Figueiredo AS; Mota LDD; Nader MM; Gardinali NR; Kevorkian YB; Salvador SBS; Pinto MA; Martinez AMB
Int J Infect Dis; 2019 Sep; 86():114-121. PubMed ID: 31279609
[TBL] [Abstract][Full Text] [Related]
51. Anti-hepatitis E virus antibody prevalence in French expatriate workers.
Vernier M; Rossi-Tamisier M; Richet H; Brouqui P; Parola P; Bouamri Y; Colson P; Gautret P
Int J Infect Dis; 2013 Nov; 17(11):e1082-4. PubMed ID: 23953700
[TBL] [Abstract][Full Text] [Related]
52. [Hepatitis E virus infection in population of non-remunerate blood donors in Shaoxing].
Sang LY; Zhuang PF; Fu LQ; Liu Y; Ge SX; Zhang J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):29-31. PubMed ID: 17429528
[TBL] [Abstract][Full Text] [Related]
53. Test performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates.
Wenzel JJ; Preiss J; Schemmerer M; Huber B; Jilg W
J Infect Dis; 2013 Feb; 207(3):497-500. PubMed ID: 23148290
[TBL] [Abstract][Full Text] [Related]
54. Seroprevalence of anti-hepatitis E antibodies and antigens among HIV-infected patients in Fars Province, southern Iran.
Shahriarirad R; Erfani A; Rastegarian M; Zeighami A; Arefkhah N; Ghorbani F; Sarvari J; Sarkari B
Virol J; 2020 Jul; 17(1):109. PubMed ID: 32680534
[TBL] [Abstract][Full Text] [Related]
55. Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina.
Munné MS; Altabert NR; Otegui M LO; Vladimirsky SN; Moreiro R; Espul MP; Espul C; Manzur A; Soto SS; Brajterman LS; González JE
Ann Hepatol; 2014; 13(5):496-502. PubMed ID: 25152981
[TBL] [Abstract][Full Text] [Related]
56. Serological and molecular study of hepatitis E virus among illegal blood donors.
Cheng XF; Wen YF; Zhu M; Zhan SW; Zheng JX; Dong C; Xiang KX; Xia XB; Wang G; Han LF
World J Gastroenterol; 2012 Mar; 18(9):986-90. PubMed ID: 22408360
[TBL] [Abstract][Full Text] [Related]
57. Seroprevalence of Hepatitis E Virus Infection among Blood Donors in Bulgaria.
Baymakova M; Terzieva K; Popov R; Grancharova E; Kundurzhiev T; Pepovich R; Tsachev I
Viruses; 2021 Mar; 13(3):. PubMed ID: 33809748
[TBL] [Abstract][Full Text] [Related]
58. Comparative sensitivity of commercial tests for hepatitis E genotype 3 virus antibody detection.
Avellon A; Morago L; Garcia-Galera del Carmen M; Munoz M; Echevarría JM
J Med Virol; 2015 Nov; 87(11):1934-9. PubMed ID: 25959136
[TBL] [Abstract][Full Text] [Related]
59. High prevalence of hepatitis E virus antibodies in Sao Paulo, Southeastern Brazil: analysis of a group of blood donors representative of the general population.
Passos-Castilho AM; Reinaldo MR; Sena A; Granato CFH
Braz J Infect Dis; 2017; 21(5):535-539. PubMed ID: 28606414
[TBL] [Abstract][Full Text] [Related]
60. Hepatitis E virus seroprevalence in pregnant women in Jiangsu, China, and postpartum evolution during six years.
Gu G; Huang H; Zhang L; Bi Y; Hu Y; Zhou YH
BMC Infect Dis; 2015 Dec; 15():560. PubMed ID: 26653888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
